Ketoftil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ketoftil

What is Ketoftil?

Ketoftil is an ophthalmic medication containing the active substance ketotifen. It belongs to a class of drugs known as antihistamines and mast cell stabilizers, designed specifically for topical use in the eyes.

Mechanism of Action

The medication works by blocking H1 receptors, which are responsible for the body's response to allergens. Additionally, it stabilizes mast cells, preventing the release of inflammatory mediators like histamine. This dual action helps manage the physiological processes associated with allergic reactions in the ocular environment.

Therapeutic Use

Ketoftil is primarily used to address the symptoms of allergic conjunctivitis. This condition occurs when the conjunctiva—the clear membrane covering the white part of the eye and the inner surface of the eyelids—becomes inflamed due to a reaction to pollen, pet dander, dust mites, or other environmental triggers.

Common symptoms managed by this medication include:

  • Ocular itching
  • Redness of the eyes
  • Swelling of the conjunctiva
  • Excessive tearing

By targeting the underlying allergic response, the medication helps reduce these localized inflammatory symptoms.

What side effects are possible with Ketoftil?

Possible Side Effects and Safety Information

The most frequently reported adverse reactions associated with Ketoftil (Ketotifen ophthalmic solution) are primarily localized to the eye.

Common (occurring in 1% to 10% of users):

  • Ocular burning or stinging upon application.
  • Conjunctival hyperemia (eye redness).
  • Headache.
  • Rhinitis (runny nose).

Less Common to Rare Adverse Reactions:

Less frequent side effects may include eye irritation, eye pain, dry eyes, blurred vision, photophobia (increased sensitivity to light), and punctate keratitis. In rare instances, systemic reactions such as dizziness, somnolence, or more severe allergic reactions (e.g., rash, swelling of the face, difficulty breathing) have been reported, necessitating immediate medical attention if they occur.


Safety Considerations and Restrictions

Contraindications

Ketoftil is contraindicated for individuals with known hypersensitivity or allergy to Ketotifen or any other component of the formulation.

Use with Contact Lenses

Soft contact lenses must be removed before applying the eye drops. The preservative, such as benzalkonium chloride, can be absorbed by and may discolor soft contact lenses. Lenses should not be reinserted until at least 10 minutes following administration. The product should not be used to treat irritation caused by contact lenses.

Pregnancy and Breastfeeding

Consultation with a healthcare professional is necessary before use during pregnancy or breastfeeding. While systemic absorption is considered low following ocular administration, human data are limited. Use during the first trimester of pregnancy should be restricted to cases where the potential benefit justifies the potential risk.

Pediatric Use

Safety and effectiveness information supports the use of this medication in children aged 3 years and older.

Overdose and Emergency Response

Overdose and When to Seek Help

The officially documented overdose profile for Ketotifen Fumarate Ophthalmic Solution primarily addresses the risk of accidental oral ingestion of the eye drops. Regulatory authorities mandate that individuals must seek immediate medical attention or contact a Poison Control Center right away if the solution is swallowed, as systemic effects may occur.

Overdose manifestations, based on experience with systemic formulations, involve the central nervous system (CNS) and cardiovascular system. Documented signs include sedation, confusion, disorientation, and in severe cases, convulsions or reversible coma. Cardiovascular effects may manifest as tachycardia (fast heartbeat) or hypotension (low blood pressure).

Documented Manifestations
Sedation, Confusion, Disorientation
Tachycardia, Hypotension
Convulsions, Reversible Coma (rare, high dose)

Treatment is defined as symptomatic and supportive. Regulatory documents state that no specific antidote is known. Procedures such as gastric lavage or the administration of activated charcoal may be considered if the ingestion is recent. A population-specific consideration notes that hyperexcitability may be observed particularly in children following systemic overdose.

Therapeutic Uses of Ketoftil

What Ketoftil Treats: Main Uses and Benefits

Ketoftil is commonly used across conditions characterized by periods of heightened symptoms related to ocular allergy, such as seasonal allergic conjunctivitis (SAC). This agent is applied in situations involving certain distressing symptoms of allergic pinkeye. The medication is generally relevant in clinical settings marked by the hallmark symptoms of eye allergy and is used when symptoms may intensify temporarily following exposure to airborne allergens like pollen or animal dander.

The medication helps address symptom clusters that may become intense or disruptive and interfere with daily functioning. The medication is used for managing symptoms, focusing on easing intense ocular itching, as well as associated redness, excessive tearing, and acute discomfort. This contributes to easing the overall symptom load during difficult episodes.

Ketoftil is commonly used during phases where the patient experiences heightened discomfort, providing symptomatic relief that helps patients cope more steadily with recurrent or episodic manifestations. The benefit is relevant for easing the impact of symptoms that become temporarily overwhelming, and assists with maintaining functional stability during symptomatic periods.


Quick Fact: Relief for Ocular Allergy Symptoms
Primary Indication Seasonal allergic conjunctivitis (SAC)
Symptom Focus Itching, redness, tearing, and stinging sensations
Context of Use During periods of increased exposure to airborne allergens
Benefit Supports relief during recurrent or episodic symptomatic periods

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility for Ketoftil (Ketotifen Ophthalmic Solution)

Ketoftil (Ketotifen Fumarate Ophthalmic Solution) is generally indicated for use in adults and children ge 3 years of age for the temporary relief of ocular itching due to allergic conjunctivitis. However, governmental regulatory documents specify clear restrictions and contraindications for its use.

Classification Population/Condition Eligibility Status
Contraindication Individuals with known hypersensitivity to ketotifen or any other product component (e.g., benzalkonium chloride) Use Prohibited
Age Restriction Children below the age of 3 years Safety and efficacy not established
Physiological State Pregnancy, particularly the first trimester Generally Contraindicated (use only if benefit justifies risk)
Special Consideration Breastfeeding mothers Caution is advised (use may be acceptable)
Formulation/Device Soft Contact Lens wearers Use Restricted (lenses must be removed before application and reinserted after at least 10 minutes)
Condition Contact lens-related irritation Should not be used to treat

All patients must adhere strictly to these eligibility rules as defined in official product labeling. The most severe restriction is the absolute contraindication due to known allergy, and the primary age restriction is based on a lack of established safety and efficacy data for children under 3 years old.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Ketoftil (Ketotifen Fumarate Ophthalmic Solution) is primarily based on officially recognized risks associated with the active ingredient's pharmacological class, given the minimal systemic absorption from the topical eye drops. The information below reflects formal statements found in government regulatory documentation.


Pharmacodynamic and Substance Interactions

Interacting Substance Category Regulatory Statement on Interaction
CNS Depressants and Oral Antihistamines Potential for potentiation of effects, derived from the oral form of ketotifen, is formally noted.
Alcohol The possibility that the active substance may potentiate the effects of alcohol is formally included in the product information.

Administration Constraints for Ocular Co-treatment

When Ketoftil is used concurrently with other topically applied eye medications, a minimum interval of at least 5 minutes must be observed between the administration of the two different products. This timing separation is a mandatory constraint detailed in the regulatory labeling.


Formal Contraindications and Exposure Alterations

There are no combinations formally classified as contraindicated due to interaction risk in the product information for the ophthalmic solution. Furthermore, the regulatory documents do not specify any metabolic (e.g., CYP-mediated) or transporter-based interactions that increase or reduce the systemic exposure of the drug, which is consistent with the very low systemic absorption of the eye drops.

Mechanism of Action

How Ketoftil Works

Ketoftil (Ketotifen Fumarate) operates through a coordinated dual mechanism that targets the fundamental steps of the allergic inflammatory cascade, encompassing both the immediate receptor-mediated response and the underlying cellular source of mediators.


️ H1-Receptor Antagonism: Immediate Signal Blockade

This domain involves the direct, non-competitive antagonism of the histamine H1-receptor found on sensory nerve endings and vascular tissue in the conjunctiva. By physically blocking this receptor, the drug prevents the primary allergic mediator, histamine, from binding and initiating the acute physiological response. This molecular blockade of nerve-fiber stimulation and vascular leakage, which underlies the fast kinetic profile of the drug's action, results in the inhibition of acute sensory signaling.


️ Mast Cell Stabilization: Sustained Cellular Mediator Control

This is the drug's sustained-action domain, where it functions as a mast cell stabilizer. Ketotifen achieves this by inhibiting the influx of calcium ions (Ca^2+) necessary for the immune cells (mast cells) to undergo degranulation. This mechanism significantly limits the subsequent release of preformed and newly synthesized inflammatory chemicals, such as histamine, leukotrienes, and platelet-activating factor (PAF). This action modulates the entire allergic cascade at the cellular level and modulates the recruitment of other inflammatory cells, like eosinophils, resulting in the modulation of inflammatory cell recruitment within the targeted pathways.

Dosage and Administration Information

How Ketoftil is Used: Official Administration Guidelines

Ketoftil (Ketotifen Fumarate Ophthalmic Solution) is an antiallergic agent used exclusively for topical ocular administration as an eye drop. The official usage guidelines specify a standardized protocol for its application, covering dosage, frequency, and specific handling instructions.


Official Dosing and Schedule

Feature Official Labeled Instruction
Route of Administration Topical Ocular (Instillation into the conjunctival sac)
Standard Dose One drop in the affected eye(s)
Frequency Twice daily (BID)
Dosing Interval Doses must be spaced approximately 8 to 12 hours apart and not exceed 2 doses per 24-hour period
Duration of Use Used for the symptomatic treatment of seasonal allergic conjunctivitis throughout the period of need

Administration Conditions and Adjustments

For proper use, guidelines provide specific instructions related to contact lenses and pediatric application:

  • Contact Lenses: Soft contact lenses must be removed prior to administering the drops. Patients must wait a minimum of 10 to 15 minutes before reinserting the lenses.
  • Contamination: To maintain sterility, the dropper tip must not touch the eye, eyelid, or any other surface during application.
  • Concomitant Medications: If other topical eye drops are used, an interval of at least 5 minutes must be observed between the medications.
  • Pediatric Use: The standard adult dosage of one drop twice daily is also recommended for children aged 3 years and older.

These instructions define the standardized method of using the medicine for consistency and efficacy.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ketoftil

Evidence Supporting Use in Seasonal Allergic Conjunctivitis

Ketoftil was evaluated in a number of clinical trials, primarily Randomized Controlled Trials (RCTs). This type of research is commonly used in research exploring how symptoms change over time compared to a non-active solution (placebo). The studies explored the drug's role in managing conditions characterized by fluctuating or episodic manifestations of ocular allergy, specifically Seasonal Allergic Conjunctivitis (SAC).

These studies applied in studies examining patient-reported experiences of key symptoms. Researchers monitored patient-reported outcomes describing perceived discomfort such as ocular itching and excessive tearing. They also observed changes in objective signs, including the appearance of conjunctival redness and swelling.

Comparison Studies and Measurement of Outcomes

Research has included trials comparing Ketoftil against a non-active solution and also used in research exploring how symptoms change over time compared to other active treatments. These studies explored specific measurements to determine how quickly the drug was evaluated in settings designed to induce symptoms. For instance, researchers examined the time it took to observe a change in symptoms, known as the onset of action, and how long that effect was observed in a single-dose setting.

Research on Duration of Use and Long-Term Outcomes

The majority of evidence was evaluated in research settings that focused on short-term symptom changes and research focusing on episodes. While some research was studied for periods of up to a few months to monitor objective signs, the follow-up durations were limited in most of the core RCTs. Long-term outcomes are not fully established, and available evidence contributes to understanding symptom patterns mainly over the span of a single allergy season.

Evidence in Specific Age Groups

Ketoftil was evaluated in research involving various age groups. Studies explored its use in adults, and separate trials examined its application in pediatric subjects, including children as young as 3 years old. However, the data for certain groups remain insufficient. For instance, there is limited information available from specific trials conducted exclusively on very young children (under 3 years of age) or on older adult populations.

What Research Remains Unclear or Limited

Analysis of the aggregated research data (meta-analyses) for this medication has noted instances of statistical heterogeneity, meaning there was variability in the reported findings for certain outcomes across different studies. Furthermore, long-term outcomes are not fully established. Some studies exploring comparisons with other active treatments reported that findings were mixed for certain outcomes depending on the specific trial and the active comparator used. Research is ongoing to characterize how symptoms evolve against all available treatments and over multi-season use.

Key Studies & References

  1. Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study
  2. Ketotifen Fumarate Ophthalmic Solution - DailyMed (FDA Labeling)

Frequently Asked Questions (FAQ)

Common questions about Ketoftil (FAQ)


Q: Is Ketoftil the same as Ketotifen?

A: Ketoftil is a brand name for an eye drop product. The active pharmaceutical ingredient contained within the drop is Ketotifen Fumarate. Official product information refers to the drug by its active ingredient, which is classified as an antihistamine and mast cell stabilizer.


Q: How quickly should I feel relief after using Ketoftil?

A: Regulatory-cited studies indicate the drug has a fast onset of action. In clinical settings, relief from eye itching was observed within minutes after administration.


Q: Can Ketoftil be used for non-allergic eye redness?

A: The product is indicated only for the temporary relief of itchy eyes caused by common outdoor and indoor allergens, such as pollen, grass, and animal dander. The product is not indicated for this use.


Q: Why do some people say Ketoftil makes them drowsy?

A: Drowsiness (somnolence) is listed as a less common side effect in the product information. Although the eye drop form has very low systemic absorption, the active substance is recognized to have a potential for central nervous system (CNS) effects, as noted with the oral form.


Q: Can I use Ketoftil with other prescribed eye drops?

  • The product information addresses the use of multiple eye drops. When this product is used concurrently with other topically applied eye medications, product labeling specifies a minimum interval of at least 5 minutes must be observed between the administrations.

Q: Is it normal to have a strange taste in my mouth after using Ketoftil?

A: A bad taste in the mouth is listed as a possible side effect in some product information for Ketotifen eye drops. This sensation may occur when the liquid drains from the eye through the tear duct into the back of the throat. Runny nose (rhinitis) is also noted as a common side effect.


Q: Why is the active ingredient in Ketoftil sometimes mentioned for asthma?

A: The active substance in Ketoftil, Ketotifen Fumarate, is classified as a mast cell stabilizer. Historically, the oral form of Ketotifen has been used as an antiasthmatic drug in some regions. The oral form is a distinct, separate product.


Q: How long does the effect of one drop of Ketoftil last?

A: Clinical studies have shown symptom relief was observed to last for up to 12 hours following a single dose of the ophthalmic solution.


Q: Is Ketoftil available over the counter?

A: Yes, in many regions, the concentration of Ketotifen Fumarate found in these eye drops is classified as a Human Over-the-Counter (OTC) Drug and is available without a prescription.


Q: Is Ketoftil safe to use every day during allergy season?

A: The product is indicated for the temporary relief of symptoms related to allergen exposure. Official regulatory information advises that if symptoms worsen or persist for more than 72 hours, use should be discontinued and professional advice sought.


Q: Are there any preservatives in Ketoftil?

A: Yes, many formulations of Ketotifen eye drops contain Benzalkonium Chloride as a preservative, which is one of the inactive ingredients listed in the official product information.


Q: What happens if I accidentally use too much Ketoftil?

A: Regulatory documents state that if the eye drops are accidentally swallowed, it is necessary to seek medical attention or contact a Poison Control Center immediately.


Q: Does Ketoftil have any known interactions with alcohol?

A: Regulatory documents formally include the possibility that the active substance may potentiate the effects of alcohol. This means it could increase or enhance the effects of alcohol.


Q: Can I use Ketoftil for general eye dryness?

A: The medication is approved for relieving itchiness due to allergic conjunctivitis. Dry eyes is also listed as a potential side effect of the drug. The product is not indicated for the treatment of general eye dryness.


Q: Can Ketoftil affect my blood pressure?

A: Systemic reactions are considered rare due to the very low absorption rate of the eye drops. Official adverse reaction lists typically do not include changes in blood pressure (hypertension or hypotension) as a common or less common side effect.


Q: How long is a typical course of treatment with Ketoftil?

A: The product is indicated for the temporary relief of symptoms caused by allergen exposure. Official regulatory information advises that if allergic symptoms persist for more than 72 hours, use should be discontinued and professional guidance sought.


Q: Do I need a prescription to get Ketoftil?

A: No, Ketotifen Fumarate eye drops (0.035% strength) are classified as an Over-the-Counter (OTC) product in many regions and do not require a prescription.


Q: What kind of eye conditions besides allergies is Ketoftil used for?

A: The product is officially indicated only for the temporary relief of itchy eyes due to specific allergic causes such as ragweed, pollen, grass, animal hair, and dander. No other uses are listed on the official product label.


Q: Is there a generic version of Ketoftil available?

A: Yes. The active ingredient, Ketotifen Fumarate ophthalmic solution, is widely available in multiple generic and other brand-name formulations worldwide.


Q: How does Ketoftil help prevent future allergic reactions?

A: The medication has a dual action, including functioning as a mast cell stabilizer. This mechanism helps inhibit mast cells from releasing chemical mediators, which modulates the allergic response and contributes to its overall protective effect.


Q: Is Ketoftil effective for pet-related eye allergies?

A: Yes. Official product information specifically indicates that the eye drops are intended for the temporary relief of itchy eyes due to allergens, including animal hair and dander.


Q: Can I use Ketoftil for hay fever eye symptoms?

A: Yes. The official indications cover the relief of itchy eyes due to allergens such as ragweed, pollen, and grass, which are the common environmental triggers associated with hay fever.


Q: What if I forget a dose of Ketoftil?

A: Instructions for a missed dose are typically found within the product labeling. Generally, if a dose is missed, individuals should not use a double dose to make up for the missed one.


Q: Does Ketoftil have any artificial colors or dyes?

A: The official product labeling lists inactive ingredients, including Benzalkonium Chloride and Glycerin. No colorants or dyes are typically listed among the required components on the label.


Q: Are there any dietary restrictions when using Ketoftil?

A: Official compendia and product information generally state that unless otherwise specifically directed by a healthcare professional, a normal diet may be continued while using the eye drops.

How should Ketoftil be stored and disposed of?

How to Store and Dispose of Ketoftil?

Storage Requirements

Official regulatory labeling dictates that Ketoftil (ketotifen fumarate ophthalmic solution) must be stored at a temperature between 4 C and 25 C (39 F and 77 F). It is mandatory to keep the product from freezing and store it away from excess heat and moisture. To maintain the medication's integrity, the bottle must be kept tightly closed when not in use, and the cap must be replaced after each application.

Stability and Child Safety

The solution should not be used if it changes color or becomes cloudy, as this signals potential instability. As with all medicines, Ketoftil must be kept out of the sight and reach of children.

Disposal

Outdated or unused medicine must be disposed of. Patients are instructed to ask a healthcare professional or pharmacist for guidance on how to properly discard any remaining medication according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ketoftil found in:

A-Z Index: